What is the equivalent dose of Cymbalta (duloxetine) for Effexor (venlafaxine) 175mg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Equivalent Dosing: Venlafaxine to Duloxetine

There is no established direct milligram-to-milligram conversion between Effexor (venlafaxine) 175mg and Cymbalta (duloxetine), but the standard therapeutic target dose of duloxetine 60mg once daily is appropriate when switching from venlafaxine 175mg, as both medications are SNRIs with similar mechanisms of action but different potencies. 1, 2

Understanding the Pharmacological Differences

  • Venlafaxine and duloxetine are not equivalent on a milligram basis because they have fundamentally different binding affinities and potencies at the serotonin and norepinephrine transporters 2

  • Venlafaxine is a relatively weak SNRI with a 30-fold difference in serotonin versus norepinephrine transporter binding, meaning it acts more like an SSRI at lower doses and only engages norepinephrine reuptake inhibition at higher doses (typically above 150mg/day) 2

  • Duloxetine is a more potent and balanced SNRI with approximately 10:1 serotonin to norepinephrine transporter binding, providing dual action even at lower doses 2

  • Venlafaxine 175mg represents a moderate-to-high dose with significant norepinephrine activity, while duloxetine 60mg once daily provides comparable dual neurotransmitter effects despite the lower milligram amount 1, 2

Recommended Switching Strategy

  • Start duloxetine at 30mg once daily for one week, then increase to 60mg once daily to minimize nausea and improve tolerability 1, 3, 4

  • The 60mg once daily dose is the standard therapeutic target for duloxetine across most indications including depression and neuropathic pain 1, 3

  • If needed for adequate response, duloxetine can be increased to 60mg twice daily (120mg/day maximum), though most patients achieve therapeutic benefit at 60mg once daily 1, 3

  • When switching from venlafaxine 175mg, you can either cross-taper (gradually reducing venlafaxine while introducing duloxetine) or perform a direct switch to duloxetine 60mg once daily, as immediate switching has been shown to be well-tolerated 5

Clinical Considerations During the Switch

  • Taking duloxetine with food significantly reduces nausea, particularly when starting at the 60mg dose rather than 30mg 4

  • The most common adverse effects when initiating duloxetine include nausea (which can be mitigated by the 30mg starting dose for one week), dry mouth, headache, dizziness, and constipation 2, 6

  • Monitor blood pressure during the transition, as both venlafaxine at 175mg and duloxetine can cause modest blood pressure elevations, though duloxetine typically produces less hypertension than higher-dose venlafaxine 1, 2, 6

  • Venlafaxine has a short half-life (5 hours for parent compound, 12 hours for active metabolite), so taper venlafaxine gradually over 2-4 weeks if cross-tapering to avoid withdrawal symptoms 2

Dosing Algorithm

For patients currently on venlafaxine 175mg:

  • Week 1: Start duloxetine 30mg once daily (with food) while continuing venlafaxine 175mg, or begin tapering venlafaxine to 150mg 7, 4

  • Week 2: Increase duloxetine to 60mg once daily and continue reducing venlafaxine (e.g., to 75-112.5mg) 7, 3

  • Weeks 3-4: Maintain duloxetine 60mg once daily and complete venlafaxine taper 7

  • Week 6-8: Assess response; if inadequate, consider increasing duloxetine to 90mg or 120mg daily 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Serotonin and Norepinephrine Reuptake Inhibitors.

Handbook of experimental pharmacology, 2019

Guideline

Duloxetine Dosing and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cross-Tapering from Escitalopram to Duloxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.